What is Dianthus Therapeutics's operating lease ROU assets?

Dianthus Therapeutics (DNTH) reported operating lease ROU assets of $1.29M in Q1 2026.

How has Dianthus Therapeutics's operating lease ROU assets changed year-over-year?

Dianthus Therapeutics's operating lease ROU assets decreased by 10.6% year-over-year, from $1.45M to $1.29M.

What does operating lease ROU assets mean?

Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Dianthus Therapeutics DNTH Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Kymera TherapeuticsKYMR

$41.74M-10.7%

Protagonist TherapeuticsPTGX

$7.39M-17.9%

TG TherapeuticsTGTX

$6.48M-6.4%

BiogenBIIB

$251.3M-27.5%

BridgeBio PharmaBBIO

$17.23M+140%

ImmunityBio, Inc.IBRX

11.1%+0.1pp

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's operating lease ROU assets?: Dianthus Therapeutics (DNTH) reported operating lease ROU assets of $1.29M in Q1 2026.
How has Dianthus Therapeutics's operating lease ROU assets changed year-over-year?: Dianthus Therapeutics's operating lease ROU assets decreased by 10.6% year-over-year, from $1.45M to $1.29M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.